Table of Contents
Chromatography Research International
Volume 2011 (2011), Article ID 893260, 6 pages
http://dx.doi.org/10.4061/2011/893260
Research Article

Development and Validation of Stability-Indicating HPTLC Determination of Tamsulosin in Bulk and Pharmaceutical Dosage Form

R. C. Patel Institute of Pharmaceutical Education and Research (RCPIPER), Shirpur, District Dhule, Maharashtra 425 405, India

Received 14 October 2010; Accepted 20 December 2010

Academic Editor: Cristina Minguillón

Copyright © 2011 S. B. Bari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Martindale, The Extra Pharmacopoeia, Council of Royal Pharmaceutical Society of Great Britain, 29th edition, 1989.
  2. S. Budavari, The Merck Index, Merck and Co. Inc., White House Station, NJ, USA, 14th edition, 1996.
  3. V. Maier, J. Horáková, J. Petr, E. Tesařová, P. Coufal, and J. Ševčík, “Chiral separation of tamsulosin by capillary electrophoresis,” Journal of Pharmaceutical and Biomedical Analysis, vol. 39, no. 3-4, pp. 691–696, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. Z. Zhang, G. Yang, G. Liang, H. Liu, and Y. Chen, “Chiral separation of Tamsulosin isomers by HPLC using cellulose Tris (3,5-dimethhylphenylcarbamate) as a chiral stationary phase,” Journal of Pharmaceutical and Biomedical Analysis, vol. 34, no. 3, pp. 689–693, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. V. V. Pande, “Simultaneous estimation of Tamsulosin hydrochloride and Dutasteride in combined dosage form by UV spectroscopy method,” Journal of Pharmacy Research, vol. 3, p. 15, 2009. View at Google Scholar
  6. M.V. Basaveswara Rao, B. C. K. Reddy, T. Srinivas Rao, and G. Venkata Rao, “Drug release method by HPLC for tamsulosin hydrochloride 0.2% and tolterodine tartrate 0.2% combination pellets,” International Journal of Chemical Engineering Research, vol. 1, no. 2, pp. 155–159, 2009. View at Google Scholar
  7. D. Patel and N. Patel, “Validated RP-HPLC and TLC methods for simultaneous estimation of tamsulosin hydrochloride and finasteride in combined dosage forms,” Acta Pharmaceutica, vol. 60, no. 2, pp. 197–205, 2010. View at Publisher · View at Google Scholar · View at PubMed
  8. J. G. Chandorkar, V. B. Kotwal, N. S. Dhande, S. G. Gurav, V. V. Pande, and P. V. Yadav, “A sensitive HPLC method for simultaneous estimation of tamsulosin hydrochloride and its impurity,” Pakistan Journal of Pharmaceutical Sciences, vol. 21, no. 3, pp. 307–310, 2008. View at Google Scholar · View at Scopus
  9. R. N. Rao, M. V. N. Kumar Talluri, A. N. Raju, D. D. Shinde, and G. S. Ramanjaneyulu, “Development of a validated RP-LC/ESI-MS-MS method for separation, identification and determination of related substances of tamsulosin in bulk drugs and formulations,” Journal of Pharmaceutical and Biomedical Analysis, vol. 46, no. 1, pp. 94–103, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. M. Qi, P. Wang, and R. Cong, “Determination of the enantiomers of tamsulosin hydrochloride and its synthetic intermediates by chiral liquid c hromatography,” Chromatographia, vol. 59, no. 3-4, pp. 251–254, 2004. View at Google Scholar · View at Scopus
  11. J. G. Chandorkar, V. B. Kotwal, N. S. Dhande, S. G. Gurav, V. V. Pande, and P. V. Yadav, “A sensitive HPLC method for simultaneous estimation of tamsulosin hydrochloride and its impurity,” Pakistan Journal of Pharmaceutical Sciences, vol. 21, no. 3, pp. 307–310, 2008. View at Google Scholar · View at Scopus
  12. L. Ding, M. Li, P. Tao, J. Yang, and Z. Zhang, “Quantitation of tamsulosin in human plasma by liquid chromatography-electrospray ionization mass spectrometry,” Journal of Chromatography B, vol. 767, no. 1, pp. 75–81, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Yamada, C. Tanaka, M. Suzuki, T. Ohkura, R. Kimura, and K. Kawabe, “Determination of α-adrenoceptor antagonists in plasma by radioreceptor assay,” Journal of Pharmaceutical and Biomedical Analysis, vol. 14, no. 3, pp. 289–294, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Hanada, N. Tochikura, and H. Ogata, “Selective binding of tamsulosin to genetic variants of human α-acid glycoprotein,” Biological and Pharmaceutical Bulletin, vol. 30, no. 8, pp. 1593–1595, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Keski-Rahkonen, O. Pärssinen, E. Leppänen, T. Mauriala, M. Lehtonen, and S. Auriola, “Determination of tamsulosin in human aqueous humor and serum by liquid chromatography-electrospray ionization tandem mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 43, no. 2, pp. 606–612, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. N. V. S. Ramakrishna, K. N. Vishwottam, S. Manoj, M. Koteshwara, S. Wishu, and D. P. Varma, “Rapid, simple and highly sensitive LC-ESI-MS/MS method for the quantification of tamsulosin in human plasma,” Biomedical Chromatography, vol. 19, no. 10, pp. 709–719, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. M. Bakshi and S. Singh, “Development of validated stability-indicating assay methods—critical review,” Journal of Pharmaceutical and Biomedical Analysis, vol. 28, no. 6, pp. 1011–1040, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. ICH Q2A Guideline, Validation of Analytical Procedures: Definition and Terminology (CPMP III/ 5626/94), ICH, Geneva, Switzerland, 1995.
  19. ICH—Guidelines Q2B, Validation of Analytical Procedures: Methodology (CPMP/ICH/281/95), ICH, Geneva, Switzerland, 1996.
  20. ICH-Guidelines Q1A- Q1E, Stability Testing of New Drug Substances and Products, 2003.